RNU6-1333P

Across TCGA pan-cancer cohorts, RNU6-1333P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-1333P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-1333P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1333P expression acts as an unfavorable survival marker, although some lineages such as LIHC and SARC show a favorable association.

HNSC, CHOL, and LIHC are the cancer types where RNU6-1333P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.390	0.586	.008	44	view →
CHOL	DFS	Tertile	All	0.103	0.511	.026	27	view →
LIHC	DFS	Tertile	III,IV	0.519	0.159	.025	18	view →
SARC	DFS	Tertile	All	0.867	0.596	.008	18	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
SKCM	OS	Tertile	II,III,IV	0.197	0.416	.013	6	view →
READ	DFS	Tertile	All	0.236	0.601	.046	6	view →
BLCA	OS	Tertile	III,IV	0.616	0.342	.039	3	view →
OV	OS	Quartile	All	0.805	0.861	.049	2	view →
LUAD	DFS	Tertile	All	0.472	0.313	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-1333P–HNSC (DFS)

Open the HNSC breakdown →